London Biotechnology Show

Home
United Kingdom
London
London Biotechnology Show

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from London Biotechnology Show, Biotechnology company, Clarence Centre 6 St. George's Circus, London.

The London Biotechnology Show is Europe’s flagship biotechnology event, connecting global leaders across red biotech to accelerate innovation, partnerships, and investment shaping the future of healthcare and life sciences.

02/11/2026

We are delighted to welcome Dr. Maria Koufali, Life Sciences Industry Director at the National Institute for Health and Care Research (NIHR), as a speaker at the London Biotechnology Show 2026.

Dr Maria Koufali is an experienced senior leader in life sciences research and innovation, bringing over 20 years of cross-sector expertise in working with global pharmaceutical companies, digital health firms, diagnostics developers, and MedTech SMEs. She holds a PhD in Pharmacology and Neuroscience, an MBA (Distinction), and is the first NHS R&D Director nationally to be awarded the Nye Bevan Executive Health Leadership Award. Maria currently leads the UK Vaccine Innovation Pathway at NIHR/DHSC, a nationally mandated clinical trials accelerator. Maria currently serves as Trustee and Chair of the Industry Advisory Board at the BBSRC-funded Quadram Institute, where she shapes translational and commercial strategy.

To hear from Dr. Maria Koufali alongside leading voices from across the life sciences industry, secure your Delegate Pass:
https://londonbiotechshow.com/register?t=delegate&utm_campaign=sm&utm_medium=social_media&utm_source=linkedin

02/11/2026

𝗘𝗻𝗵𝗮𝗻𝗰𝗲 𝗬𝗼𝘂𝗿 𝗘𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 𝗮𝘁 𝗟𝗼𝗻𝗱𝗼𝗻 𝗕𝗶𝗼𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗦𝗵𝗼𝘄 𝟮𝟬𝟮𝟲 𝘄𝗶𝘁𝗵 𝗘𝘁𝘁𝗲𝗻𝗱!

Make every connection count at London Biotechnology Show 2026 with Ettend, the official event networking app.

Connect with biotechnology and life sciences professionals, discover attendees and exhibitors, exchange messages, schedule meetings, and explore new opportunities for collaboration and growth, all in one place.

Your next breakthrough collaboration could start with a single connection. Download Ettend and build your network before the show!

📅 𝟭𝟴–𝟭𝟵 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟮𝟬𝟮𝟲
📍 𝗘𝘅𝗖𝗲𝗟 𝗟𝗼𝗻𝗱𝗼𝗻, 𝗨𝗞

Download Ettend now and start building valuable connections at London Biotechnology Show 2026!
https://ettend.valiantandcompany.com/?utm_campaign=socialmedia&utm_medium=others&utm_source=others

02/11/2026

We are pleased to welcome Metinor as an exhibitor at the London Biotechnology Show 2026.

Metinor provides continuous environmental monitoring for laboratories, pharmaceutical facilities and other regulated environments. Its wireless sensors monitor critical conditions, with automatic alerts and complete audit trails of monitoring data. The system is designed to remove much of the complexity associated with traditional monitoring.

Connect with Metinor and discover innovative solutions supporting the biotechnology and life sciences industry at the London Biotechnology Show 2026.

Secure your FREE visitor pass: https://londonbiotechshow.com/register?t=delegate&utm_campaign=sm&utm_medium=social_media&utm_source=linkedin

30/10/2026

We are pleased to welcome Arensia Exploratory Medicine as a Lead Generation Sponsor at the London Biotechnology Show 2026.

At ARENSIA Exploratory Medicine, 2 out of 3 trials exceed their original enrollment targets. With 15 dedicated research clinics across 8 countries, over 800 full-time employees, and advanced clinical infrastructure, the company accelerates complex Phase I/II patient studies, helping biotech and pharmaceutical companies reach proof of concept faster.

Connect with Arensia Exploratory Medicine at the London Biotechnology Show 2026.

Secure your FREE visitor pass: https://londonbiotechshow.com/register?t=delegate&utm_campaign=sm&utm_medium=social_media&utm_source=linkedin

30/10/2026

We are pleased to welcome Avion Medical as an exhibitor at the London Biotechnology Show 2026.

Avion is a leading full-service CRO and research imaging specialist delivering end-to-end clinical trial solutions across Australia and globally. Headquartered in Melbourne, Avion supports pharmaceutical, biotechnology and medical device companies across all stages of clinical development, with particular expertise in early-phase trials, oncology, nuclear medicine and theranostics, radiopharmaceuticals and research imaging, as well as dermatology, nutrition and other therapeutic areas.

Avion combines deep clinical research experience with specialised expertise in complex and early-stage development, providing tailored solutions that support efficient, high-quality trial ex*****on. Its experienced team works closely with sponsors, investigators and industry partners to navigate the complexities of clinical development and accelerate the delivery of innovative treatments.
With a strong understanding of Australia’s highly favourable clinical research environment and extensive international experience, Avion provides the expertise, infrastructure and specialised capabilities required to deliver complex clinical studies successfully. Its niche expertise in radiopharmaceutical and theranostic development, including research imaging and dosimetry, further positions Avion as a specialist partner for the evolving field of precision medicine.

Connect with Avion Medical and discover innovative solutions supporting the biotechnology and life sciences industry at the London Biotechnology Show 2026.

Secure your FREE visitor pass: https://londonbiotechshow.com/register?t=delegate&utm_campaign=sm&utm_medium=social_media&utm_source=linkedin

29/10/2026

We are pleased to welcome Nikole Kimes, Ph.D., Co-Founder and Chief Executive Officer at Siolta Therapeutics, as a speaker at the London Biotechnology Show 2026.

Dr. Kimes leads the strategic vision, corporate development, and cross-functional operations of a clinical-stage biotechnology company pioneering novel biologics, known as live biotherapeutic products (LBPs), that target the root causes of inflammatory and infectious diseases. Under her leadership, multiple programs, including the lead candidate STMC-103H, have advanced through preclinical validation, anaerobic manufacturing scale-up, key regulatory milestones such as FDA Fast Track designation, and clinical trials, while securing substantial investor and non-dilutive funding to fuel growth and innovation.

Trained in microbial ecology and host–microbe interactions, Dr. Kimes conducted her postdoctoral research in Dr. Susan Lynch’s lab at UCSF, where she co-invented the foundational technology behind Siolta’s therapeutic platform. Building on that scientific foundation, she now oversees the translation of microbiome science into patient-focused therapeutics addressing large unmet medical needs.

In addition to serving as a member of Siolta’s Board of Directors, Dr. Kimes also served as Chair of the Microbiome Therapeutics Innovation Group (MTIG) from 2022–2025 and remains active in MTIG, Women In Bio (WIB), Springboard Enterprises, and the Food Allergy Biomarker Alliance (FABA). She is recognized for bridging scientific innovation with strategic leadership to advance the next generation of microbiome-based medicines.

To hear from Nikole Kimes alongside leading voices from across the life sciences industry, secure your Delegate Pass:
https://londonbiotechshow.com/register?t=delegate&utm_campaign=sm&utm_medium=social_media&utm_source=linkedin

29/10/2026

We are pleased to welcome Global R&D as an Exhibitor at the London Biotechnology Show 2026.

Global R&D is a dedicated R&D Tax Incentive advisory with a truly global reach.

The company provides expert guidance on establishing a presence in Australia, and on R&D Tax Incentive matters to companies from Australia, China, the EU, Singapore, Taiwan, the UK, and the USA.

Founder and Director Dr Pavel Reddy holds a PhD in Biological Sciences, is a Registered R&D Tax Advisor with the Australian Government’s Tax Practitioners Board and has more than 19 years of experience submitting R&D tax claims.

Connect with Global R&D and discover innovative solutions supporting the biotechnology and life sciences industry at the London Biotechnology Show 2026.

Secure your FREE visitor pass: https://londonbiotechshow.com/register?t=delegate&utm_campaign=sm&utm_medium=social_media&utm_source=linkedin

28/10/2026

We are pleased to welcome Alicja Fiedorowicz, Associate Director, CMC at Allucent, as a speaker at the London Biotechnology Show 2026.

Alicja Fiedorowicz, MSc, is an Associate Director, CMC with over 14 years of professional experience in the development and CMC regulation of biological products and advanced therapies. She has extensive experience with regulatory submissions and interactions with health authorities across the USA, EU and UK.

Her expertise spans allogeneic and autologous genetically modified cell therapies, viral vectors including LV, AAV and Adenovirus, as well as plasmids, mRNA, CRISPR-Cas systems and various biologics. She has technical expertise in analytical development, quality control, product and process characterisation, comparability evaluations, and process and analytical validation.

Alicja has written and reviewed regulatory documentation, including MAA/BLA/IND/CTA submissions and scientific advice briefing packages. She regularly presents at scientific conferences and participates in expert groups, sharing insights on technical challenges and CMC strategies for advanced therapies. Her previous experience includes roles at Proxima Concepts, Pfizer, GSK, Orchard Therapeutics and Dark Horse Consulting. She holds an MSc in Biotechnology from Wroclaw University of Technology.

To hear from Alicja Fiedorowicz alongside leading voices from across the life sciences industry, secure your Delegate Pass:
https://londonbiotechshow.com/register?t=delegate&utm_campaign=sm&utm_medium=social_media&utm_source=linkedin

28/10/2026

𝗝𝘂𝘀𝘁 𝟯 𝗪𝗲𝗲𝗸𝘀 𝘁𝗼 𝗚𝗼 𝘁𝗼 𝗟𝗼𝗻𝗱𝗼𝗻 𝗕𝗶𝗼𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗦𝗵𝗼𝘄 𝟮𝟬𝟮𝟲!

The countdown is on for one of the key meeting points for the global biotechnology community. Industry leaders, researchers, innovators and technology providers will come together to explore scientific advancements, exchange knowledge and discover opportunities for collaboration.

Join the global life sciences community on 𝟭𝟴–𝟭𝟵 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 at 𝗘𝘅𝗖𝗲𝗟 𝗟𝗼𝗻𝗱𝗼𝗻 to exchange insights, discover innovations and build valuable industry connections.
Register today for your FREE visitor pass and secure your place.

https://londonbiotechshow.com/register?t=delegate&utm_campaign=sm&utm_medium=social_media&utm_source=linkedin

27/10/2026

We are delighted to welcome Dr Steven Walker, Director at St GilesMedical London & Berlin, as a Speaker at the London Biotechnology Show 2026.

Steven is a gifted medical writer, researcher, and educator. He has degrees in medicine, education, and clinical oncology. During his training, Steven spent time in the UK, USA, and Germany. He leads the team at St GilesMedical in London and Berlin (www.stgmed.com). The focus of his activity is to support biotech, patients, and healthcare professionals through effective delivery of health information.

St GilesMedical is an award-winning communication company specialising in medical & regulatory writing, health films, teaching, research management, and educational meeting. Steven is a member of EMWA, a tutor at the University of Applied Sciences and holds an Honorary Lectureship at University College London. He is secretary and trustee of a health charity (www.forgottenpatients.org).

To hear from Dr Steven Walker alongside leading voices from across the life sciences industry, secure your Delegate Pass:
https://londonbiotechshow.com/register?t=delegate&utm_campaign=sm&utm_medium=social_media&utm_source=linkedin

Address

Clarence Centre 6 St. George's Circus
London

Website

https://biotechnologyshow.com/

Alerts

Be the first to know and let us send you an email when London Biotechnology Show posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.